7 results  1 of 1 

1 A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans
Jack Alistair Sargeant, Joseph Henson, James Adam King, Thomas Yates, Kamlesh Khunti, Melanie Jane Davies
Endocrinol Metab.2019;34(3):247-262.   Published online 2019 September 26     DOI: http://dx.doi.org/10.3803/EnM.2019.34.3.247
   
2 Cardiovascular Outcome Trials of Incretin Therapy (Dipeptidyl Peptidase-4 Inhibitors/Glucagon-Like Peptide-1 Receptor Agonist)
In-Kyung Jeong
J Lipid Atheroscler.2018;7(1):32-41.   Published online 2018 June 27     DOI: http://dx.doi.org/10.12997/jla.2018.7.1.32
      
3 Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
Hyun Jin Kim
J Korean Diabetes.2018;19(1):35-40.   Published online 2018 March 27     DOI: http://dx.doi.org/10.4093/jkd.2018.19.1.35
      
4 Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
Hyun Jin Kim, Seok O Park, Seung-Hyun Ko, Sang Youl Rhee, Kyu-Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Byung-Wan Lee, Jin Hwa Kim, Kyung Mook Choi,
Diabetes Metab J.2017;41(6):423-429.   Published online 2017 December 19     DOI: http://dx.doi.org/10.4093/dmj.2017.41.6.423
      
5 New anti-diabetic agents
Doo-Man Kim
J Korean Med Assoc.2017;60(12):992-997.   Published online 2017 December 14     DOI: http://dx.doi.org/10.5124/jkma.2017.60.12.992
      
6 An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
Suk Chon, Jean-François Gautier
Diabetes Metab J.2016;40(2):99-114.   Published online 2016 April 25     DOI: http://dx.doi.org/10.4093/dmj.2016.40.2.99
      
7 The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in Korea
Seungjoon Oh, Suk Chon, Kyu Jeong Ahn, In-Kyung Jeong, Byung-Joon Kim, Jun Goo Kang
Diabetes Metab J.2015;39(3):177-187.   Published online 2015 June 15     DOI: http://dx.doi.org/10.4093/dmj.2015.39.3.177
      

 1 of 1